Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$111,070,232
+$55,544,608 QoQ
Shares Held
298,841
+39.0% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 419 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. KRYS ranks #29 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in KRYS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,070,232 | 298,841 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $55,525,624 | 214,949 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $72,365,652 | 293,525 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $61,476,572 | 348,250 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $72,903,422 | 530,361 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $42,125,292 | 233,640 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $43,422,234 | 277,175 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $54,855,467 | 301,354 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $77,556,864 | 422,331 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $77,323,750 | 434,574 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $28,292,254 | 228,053 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $21,383,904 | 184,344 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $22,885,485 | 194,936 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $20,644,271 | 257,860 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $11,692,950 | 147,601 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $9,924,234 | 142,385 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $10,751,430 | 163,744 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $9,052,567 | 136,047 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,718,051 | 53,153 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,113,377 | 21,325 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $9,238,344 | 135,858 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $14,058,413 | 182,482 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $12,917,040 | 215,284 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $11,844,862 | 275,142 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $11,779,682 | 284,396 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,357,035 | 100,764 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||